0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Cannabis Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-25U11328
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Grade Cannabis Market Research Report 2022
BUY CHAPTERS

Global Pharmaceutical Grade Cannabis Market Research Report 2024

Code: QYRE-Auto-25U11328
Report
April 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Grade Cannabis Market Size

The global Pharmaceutical Grade Cannabis market was valued at US$ 849.5 million in 2023 and is anticipated to reach US$ 1355.3 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.

Pharmaceutical Grade Cannabis Market

Pharmaceutical Grade Cannabis Market

"Pharmaceutical grade cannabis" is a term used to describe cannabis products that meet the high-quality and safety standards required for pharmaceutical use. This designation implies that the cannabis has been cultivated, processed, and tested in a manner consistent with pharmaceutical regulations and guidelines.
Legalization and Regulation: Many countries and states were moving towards the legalization and regulation of medical cannabis. This trend was expected to continue, opening up new markets for pharmaceutical-grade cannabis products.
Clinical Trials: Pharmaceutical companies and research institutions were conducting clinical trials to evaluate the safety and efficacy of cannabis-based medications for various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and more.
Product Diversification: The market was witnessing the development of a wide range of pharmaceutical-grade cannabis products, including capsules, tinctures, transdermal patches, and inhalers. These products were designed to provide consistent dosing and delivery methods.
Quality Control: As the pharmaceutical-grade cannabis market matured, there was a greater emphasis on quality control and standardization of production processes. Ensuring product consistency and purity was a top priority.
International Expansion: Companies were exploring opportunities to expand into international markets as more countries considered legalizing medical cannabis. Exporting pharmaceutical-grade cannabis products to countries with established medical cannabis programs became a strategic focus for some companies.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Cannabis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Cannabis.

Report Scope

The Pharmaceutical Grade Cannabis market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Grade Cannabis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Cannabis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Grade Cannabis Market Report

Report Metric Details
Report Name Pharmaceutical Grade Cannabis Market
Accounted market size in 2023 US$ 849.5 million
Forecasted market size in 2030 US$ 1355.3 million
CAGR 7.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Dronabinol
  • Nabilone
  • Nabiximols
  • Cannabidiol
  • Others
Segment by Application
  • Oral Medications
  • Topical Medications
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna, Village Farms, Aurora, Canopy Growth, Cresco Labs, Glass House Farms, Organigram, C3 International, CannTrust, FlowerOne, Solaris Farms, 7Acres, ThePharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Grade Cannabis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceutical Grade Cannabis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Grade Cannabis Market growing?

Ans: The Pharmaceutical Grade Cannabis Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Pharmaceutical Grade Cannabis Market size in 2030?

Ans: The Pharmaceutical Grade Cannabis Market size in 2030 will be US$ 1355.3 million.

Who are the main players in the Pharmaceutical Grade Cannabis Market report?

Ans: The main players in the Pharmaceutical Grade Cannabis Market are Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna, Village Farms, Aurora, Canopy Growth, Cresco Labs, Glass House Farms, Organigram, C3 International, CannTrust, FlowerOne, Solaris Farms, 7Acres, ThePharm

What are the Application segmentation covered in the Pharmaceutical Grade Cannabis Market report?

Ans: The Applications covered in the Pharmaceutical Grade Cannabis Market report are Oral Medications, Topical Medications

What are the Type segmentation covered in the Pharmaceutical Grade Cannabis Market report?

Ans: The Types covered in the Pharmaceutical Grade Cannabis Market report are Dronabinol, Nabilone, Nabiximols, Cannabidiol, Others

1 Pharmaceutical Grade Cannabis Market Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Cannabis
1.2 Pharmaceutical Grade Cannabis Segment by Type
1.2.1 Global Pharmaceutical Grade Cannabis Market Value Comparison by Type (2024-2030)
1.2.2 Dronabinol
1.2.3 Nabilone
1.2.4 Nabiximols
1.2.5 Cannabidiol
1.2.6 Others
1.3 Pharmaceutical Grade Cannabis Segment by Application
1.3.1 Global Pharmaceutical Grade Cannabis Market Value by Application: (2024-2030)
1.3.2 Oral Medications
1.3.3 Topical Medications
1.4 Global Pharmaceutical Grade Cannabis Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Grade Cannabis Revenue 2019-2030
1.4.2 Global Pharmaceutical Grade Cannabis Sales 2019-2030
1.4.3 Global Pharmaceutical Grade Cannabis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Grade Cannabis Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Cannabis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Grade Cannabis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Grade Cannabis Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Grade Cannabis Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Grade Cannabis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Cannabis, Product Type & Application
2.7 Pharmaceutical Grade Cannabis Market Competitive Situation and Trends
2.7.1 Pharmaceutical Grade Cannabis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Grade Cannabis Players Market Share by Revenue
2.7.3 Global Pharmaceutical Grade Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Grade Cannabis Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Grade Cannabis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Grade Cannabis Global Pharmaceutical Grade Cannabis Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Grade Cannabis Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Grade Cannabis Sales by Region: 2025-2030
3.3 Global Pharmaceutical Grade Cannabis Global Pharmaceutical Grade Cannabis Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Grade Cannabis Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Grade Cannabis Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Grade Cannabis Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Cannabis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Grade Cannabis Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Grade Cannabis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Cannabis Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Cannabis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Grade Cannabis Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Grade Cannabis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Cannabis Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Grade Cannabis Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Grade Cannabis Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Grade Cannabis Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Grade Cannabis Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Cannabis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Grade Cannabis Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Grade Cannabis Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Grade Cannabis Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Cannabis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Grade Cannabis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Grade Cannabis Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Cannabis Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Grade Cannabis Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Grade Cannabis Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Grade Cannabis Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Grade Cannabis Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Grade Cannabis Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Grade Cannabis Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Grade Cannabis Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Grade Cannabis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Grade Cannabis Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Grade Cannabis Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Grade Cannabis Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Grade Cannabis Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Grade Cannabis Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Grade Cannabis Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Grade Cannabis Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Grade Cannabis Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Grade Cannabis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ultra Health
6.1.1 Ultra Health Corporation Information
6.1.2 Ultra Health Description and Business Overview
6.1.3 Ultra Health Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ultra Health Pharmaceutical Grade Cannabis Product Portfolio
6.1.5 Ultra Health Recent Developments/Updates
6.2 Mammoth Farms
6.2.1 Mammoth Farms Corporation Information
6.2.2 Mammoth Farms Description and Business Overview
6.2.3 Mammoth Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mammoth Farms Pharmaceutical Grade Cannabis Product Portfolio
6.2.5 Mammoth Farms Recent Developments/Updates
6.3 Palo Verde Center
6.3.1 Palo Verde Center Corporation Information
6.3.2 Palo Verde Center Description and Business Overview
6.3.3 Palo Verde Center Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Palo Verde Center Pharmaceutical Grade Cannabis Product Portfolio
6.3.5 Palo Verde Center Recent Developments/Updates
6.4 Hexo Corp
6.4.1 Hexo Corp Corporation Information
6.4.2 Hexo Corp Description and Business Overview
6.4.3 Hexo Corp Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hexo Corp Pharmaceutical Grade Cannabis Product Portfolio
6.4.5 Hexo Corp Recent Developments/Updates
6.5 Bright Green Corporation
6.5.1 Bright Green Corporation Corporation Information
6.5.2 Bright Green Corporation Description and Business Overview
6.5.3 Bright Green Corporation Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bright Green Corporation Pharmaceutical Grade Cannabis Product Portfolio
6.5.5 Bright Green Corporation Recent Developments/Updates
6.6 Copperstate Farms
6.6.1 Copperstate Farms Corporation Information
6.6.2 Copperstate Farms Description and Business Overview
6.6.3 Copperstate Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Copperstate Farms Pharmaceutical Grade Cannabis Product Portfolio
6.6.5 Copperstate Farms Recent Developments/Updates
6.7 Los Suenos Farms
6.6.1 Los Suenos Farms Corporation Information
6.6.2 Los Suenos Farms Description and Business Overview
6.6.3 Los Suenos Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Los Suenos Farms Pharmaceutical Grade Cannabis Product Portfolio
6.7.5 Los Suenos Farms Recent Developments/Updates
6.8 Canna
6.8.1 Canna Corporation Information
6.8.2 Canna Description and Business Overview
6.8.3 Canna Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Canna Pharmaceutical Grade Cannabis Product Portfolio
6.8.5 Canna Recent Developments/Updates
6.9 Village Farms
6.9.1 Village Farms Corporation Information
6.9.2 Village Farms Description and Business Overview
6.9.3 Village Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Village Farms Pharmaceutical Grade Cannabis Product Portfolio
6.9.5 Village Farms Recent Developments/Updates
6.10 Aurora
6.10.1 Aurora Corporation Information
6.10.2 Aurora Description and Business Overview
6.10.3 Aurora Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aurora Pharmaceutical Grade Cannabis Product Portfolio
6.10.5 Aurora Recent Developments/Updates
6.11 Canopy Growth
6.11.1 Canopy Growth Corporation Information
6.11.2 Canopy Growth Pharmaceutical Grade Cannabis Description and Business Overview
6.11.3 Canopy Growth Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Canopy Growth Pharmaceutical Grade Cannabis Product Portfolio
6.11.5 Canopy Growth Recent Developments/Updates
6.12 Cresco Labs
6.12.1 Cresco Labs Corporation Information
6.12.2 Cresco Labs Pharmaceutical Grade Cannabis Description and Business Overview
6.12.3 Cresco Labs Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cresco Labs Pharmaceutical Grade Cannabis Product Portfolio
6.12.5 Cresco Labs Recent Developments/Updates
6.13 Glass House Farms
6.13.1 Glass House Farms Corporation Information
6.13.2 Glass House Farms Pharmaceutical Grade Cannabis Description and Business Overview
6.13.3 Glass House Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Glass House Farms Pharmaceutical Grade Cannabis Product Portfolio
6.13.5 Glass House Farms Recent Developments/Updates
6.14 Organigram
6.14.1 Organigram Corporation Information
6.14.2 Organigram Pharmaceutical Grade Cannabis Description and Business Overview
6.14.3 Organigram Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Organigram Pharmaceutical Grade Cannabis Product Portfolio
6.14.5 Organigram Recent Developments/Updates
6.15 C3 International
6.15.1 C3 International Corporation Information
6.15.2 C3 International Pharmaceutical Grade Cannabis Description and Business Overview
6.15.3 C3 International Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.15.4 C3 International Pharmaceutical Grade Cannabis Product Portfolio
6.15.5 C3 International Recent Developments/Updates
6.16 CannTrust
6.16.1 CannTrust Corporation Information
6.16.2 CannTrust Pharmaceutical Grade Cannabis Description and Business Overview
6.16.3 CannTrust Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CannTrust Pharmaceutical Grade Cannabis Product Portfolio
6.16.5 CannTrust Recent Developments/Updates
6.17 FlowerOne
6.17.1 FlowerOne Corporation Information
6.17.2 FlowerOne Pharmaceutical Grade Cannabis Description and Business Overview
6.17.3 FlowerOne Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.17.4 FlowerOne Pharmaceutical Grade Cannabis Product Portfolio
6.17.5 FlowerOne Recent Developments/Updates
6.18 Solaris Farms
6.18.1 Solaris Farms Corporation Information
6.18.2 Solaris Farms Pharmaceutical Grade Cannabis Description and Business Overview
6.18.3 Solaris Farms Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Solaris Farms Pharmaceutical Grade Cannabis Product Portfolio
6.18.5 Solaris Farms Recent Developments/Updates
6.19 7Acres
6.19.1 7Acres Corporation Information
6.19.2 7Acres Pharmaceutical Grade Cannabis Description and Business Overview
6.19.3 7Acres Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.19.4 7Acres Pharmaceutical Grade Cannabis Product Portfolio
6.19.5 7Acres Recent Developments/Updates
6.20 ThePharm
6.20.1 ThePharm Corporation Information
6.20.2 ThePharm Pharmaceutical Grade Cannabis Description and Business Overview
6.20.3 ThePharm Pharmaceutical Grade Cannabis Sales, Revenue and Gross Margin (2019-2024)
6.20.4 ThePharm Pharmaceutical Grade Cannabis Product Portfolio
6.20.5 ThePharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Cannabis Industry Chain Analysis
7.2 Pharmaceutical Grade Cannabis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Cannabis Production Mode & Process
7.4 Pharmaceutical Grade Cannabis Sales and Marketing
7.4.1 Pharmaceutical Grade Cannabis Sales Channels
7.4.2 Pharmaceutical Grade Cannabis Distributors
7.5 Pharmaceutical Grade Cannabis Customers
8 Pharmaceutical Grade Cannabis Market Dynamics
8.1 Pharmaceutical Grade Cannabis Industry Trends
8.2 Pharmaceutical Grade Cannabis Market Drivers
8.3 Pharmaceutical Grade Cannabis Market Challenges
8.4 Pharmaceutical Grade Cannabis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Pharmaceutical Grade Cannabis Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Pharmaceutical Grade Cannabis Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Pharmaceutical Grade Cannabis Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Pharmaceutical Grade Cannabis Sales (Tons) of Key Manufacturers (2019-2024)
    Table 5. Global Pharmaceutical Grade Cannabis Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Pharmaceutical Grade Cannabis Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Pharmaceutical Grade Cannabis Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Pharmaceutical Grade Cannabis Average Price (US$/Ton) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Pharmaceutical Grade Cannabis, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Pharmaceutical Grade Cannabis, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Pharmaceutical Grade Cannabis, Product Type & Application
    Table 12. Global Key Manufacturers of Pharmaceutical Grade Cannabis, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pharmaceutical Grade Cannabis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Cannabis as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pharmaceutical Grade Cannabis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Pharmaceutical Grade Cannabis Sales by Region (2019-2024) & (Tons)
    Table 18. Global Pharmaceutical Grade Cannabis Sales Market Share by Region (2019-2024)
    Table 19. Global Pharmaceutical Grade Cannabis Sales by Region (2025-2030) & (Tons)
    Table 20. Global Pharmaceutical Grade Cannabis Sales Market Share by Region (2025-2030)
    Table 21. Global Pharmaceutical Grade Cannabis Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Pharmaceutical Grade Cannabis Revenue Market Share by Region (2019-2024)
    Table 23. Global Pharmaceutical Grade Cannabis Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Pharmaceutical Grade Cannabis Revenue Market Share by Region (2025-2030)
    Table 25. North America Pharmaceutical Grade Cannabis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Pharmaceutical Grade Cannabis Sales by Country (2019-2024) & (Tons)
    Table 27. North America Pharmaceutical Grade Cannabis Sales by Country (2025-2030) & (Tons)
    Table 28. North America Pharmaceutical Grade Cannabis Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Pharmaceutical Grade Cannabis Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Pharmaceutical Grade Cannabis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Pharmaceutical Grade Cannabis Sales by Country (2019-2024) & (Tons)
    Table 32. Europe Pharmaceutical Grade Cannabis Sales by Country (2025-2030) & (Tons)
    Table 33. Europe Pharmaceutical Grade Cannabis Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Pharmaceutical Grade Cannabis Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Pharmaceutical Grade Cannabis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Pharmaceutical Grade Cannabis Sales by Region (2019-2024) & (Tons)
    Table 37. Asia Pacific Pharmaceutical Grade Cannabis Sales by Region (2025-2030) & (Tons)
    Table 38. Asia Pacific Pharmaceutical Grade Cannabis Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Pharmaceutical Grade Cannabis Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Pharmaceutical Grade Cannabis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Pharmaceutical Grade Cannabis Sales by Country (2019-2024) & (Tons)
    Table 42. Latin America Pharmaceutical Grade Cannabis Sales by Country (2025-2030) & (Tons)
    Table 43. Latin America Pharmaceutical Grade Cannabis Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Pharmaceutical Grade Cannabis Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Pharmaceutical Grade Cannabis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Pharmaceutical Grade Cannabis Sales by Country (2019-2024) & (Tons)
    Table 47. Middle East & Africa Pharmaceutical Grade Cannabis Sales by Country (2025-2030) & (Tons)
    Table 48. Middle East & Africa Pharmaceutical Grade Cannabis Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Pharmaceutical Grade Cannabis Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Pharmaceutical Grade Cannabis Sales (Tons) by Type (2019-2024)
    Table 51. Global Pharmaceutical Grade Cannabis Sales (Tons) by Type (2025-2030)
    Table 52. Global Pharmaceutical Grade Cannabis Sales Market Share by Type (2019-2024)
    Table 53. Global Pharmaceutical Grade Cannabis Sales Market Share by Type (2025-2030)
    Table 54. Global Pharmaceutical Grade Cannabis Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Pharmaceutical Grade Cannabis Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Pharmaceutical Grade Cannabis Revenue Market Share by Type (2019-2024)
    Table 57. Global Pharmaceutical Grade Cannabis Revenue Market Share by Type (2025-2030)
    Table 58. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Type (2019-2024)
    Table 59. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Type (2025-2030)
    Table 60. Global Pharmaceutical Grade Cannabis Sales (Tons) by Application (2019-2024)
    Table 61. Global Pharmaceutical Grade Cannabis Sales (Tons) by Application (2025-2030)
    Table 62. Global Pharmaceutical Grade Cannabis Sales Market Share by Application (2019-2024)
    Table 63. Global Pharmaceutical Grade Cannabis Sales Market Share by Application (2025-2030)
    Table 64. Global Pharmaceutical Grade Cannabis Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Pharmaceutical Grade Cannabis Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Pharmaceutical Grade Cannabis Revenue Market Share by Application (2019-2024)
    Table 67. Global Pharmaceutical Grade Cannabis Revenue Market Share by Application (2025-2030)
    Table 68. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Application (2019-2024)
    Table 69. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Application (2025-2030)
    Table 70. Ultra Health Corporation Information
    Table 71. Ultra Health Description and Business Overview
    Table 72. Ultra Health Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 73. Ultra Health Pharmaceutical Grade Cannabis Product
    Table 74. Ultra Health Recent Developments/Updates
    Table 75. Mammoth Farms Corporation Information
    Table 76. Mammoth Farms Description and Business Overview
    Table 77. Mammoth Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 78. Mammoth Farms Pharmaceutical Grade Cannabis Product
    Table 79. Mammoth Farms Recent Developments/Updates
    Table 80. Palo Verde Center Corporation Information
    Table 81. Palo Verde Center Description and Business Overview
    Table 82. Palo Verde Center Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 83. Palo Verde Center Pharmaceutical Grade Cannabis Product
    Table 84. Palo Verde Center Recent Developments/Updates
    Table 85. Hexo Corp Corporation Information
    Table 86. Hexo Corp Description and Business Overview
    Table 87. Hexo Corp Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 88. Hexo Corp Pharmaceutical Grade Cannabis Product
    Table 89. Hexo Corp Recent Developments/Updates
    Table 90. Bright Green Corporation Corporation Information
    Table 91. Bright Green Corporation Description and Business Overview
    Table 92. Bright Green Corporation Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 93. Bright Green Corporation Pharmaceutical Grade Cannabis Product
    Table 94. Bright Green Corporation Recent Developments/Updates
    Table 95. Copperstate Farms Corporation Information
    Table 96. Copperstate Farms Description and Business Overview
    Table 97. Copperstate Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 98. Copperstate Farms Pharmaceutical Grade Cannabis Product
    Table 99. Copperstate Farms Recent Developments/Updates
    Table 100. Los Suenos Farms Corporation Information
    Table 101. Los Suenos Farms Description and Business Overview
    Table 102. Los Suenos Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 103. Los Suenos Farms Pharmaceutical Grade Cannabis Product
    Table 104. Los Suenos Farms Recent Developments/Updates
    Table 105. Canna Corporation Information
    Table 106. Canna Description and Business Overview
    Table 107. Canna Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 108. Canna Pharmaceutical Grade Cannabis Product
    Table 109. Canna Recent Developments/Updates
    Table 110. Village Farms Corporation Information
    Table 111. Village Farms Description and Business Overview
    Table 112. Village Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 113. Village Farms Pharmaceutical Grade Cannabis Product
    Table 114. Village Farms Recent Developments/Updates
    Table 115. Aurora Corporation Information
    Table 116. Aurora Description and Business Overview
    Table 117. Aurora Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 118. Aurora Pharmaceutical Grade Cannabis Product
    Table 119. Aurora Recent Developments/Updates
    Table 120. Canopy Growth Corporation Information
    Table 121. Canopy Growth Description and Business Overview
    Table 122. Canopy Growth Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 123. Canopy Growth Pharmaceutical Grade Cannabis Product
    Table 124. Canopy Growth Recent Developments/Updates
    Table 125. Cresco Labs Corporation Information
    Table 126. Cresco Labs Description and Business Overview
    Table 127. Cresco Labs Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 128. Cresco Labs Pharmaceutical Grade Cannabis Product
    Table 129. Cresco Labs Recent Developments/Updates
    Table 130. Glass House Farms Corporation Information
    Table 131. Glass House Farms Description and Business Overview
    Table 132. Glass House Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 133. Glass House Farms Pharmaceutical Grade Cannabis Product
    Table 134. Glass House Farms Recent Developments/Updates
    Table 135. Organigram Corporation Information
    Table 136. Organigram Description and Business Overview
    Table 137. Organigram Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 138. Organigram Pharmaceutical Grade Cannabis Product
    Table 139. Organigram Recent Developments/Updates
    Table 140. C3 International Corporation Information
    Table 141. C3 International Description and Business Overview
    Table 142. C3 International Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 143. C3 International Pharmaceutical Grade Cannabis Product
    Table 144. C3 International Recent Developments/Updates
    Table 145. CannTrust Corporation Information
    Table 146. CannTrust Description and Business Overview
    Table 147. CannTrust Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 148. CannTrust Pharmaceutical Grade Cannabis Product
    Table 149. CannTrust Recent Developments/Updates
    Table 150. FlowerOne Corporation Information
    Table 151. FlowerOne Description and Business Overview
    Table 152. FlowerOne Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 153. FlowerOne Pharmaceutical Grade Cannabis Product
    Table 154. FlowerOne Recent Developments/Updates
    Table 155. Solaris Farms Corporation Information
    Table 156. Solaris Farms Description and Business Overview
    Table 157. Solaris Farms Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 158. Solaris Farms Pharmaceutical Grade Cannabis Product
    Table 159. Solaris Farms Recent Developments/Updates
    Table 160. 7Acres Corporation Information
    Table 161. 7Acres Description and Business Overview
    Table 162. 7Acres Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 163. 7Acres Pharmaceutical Grade Cannabis Product
    Table 164. 7Acres Recent Developments/Updates
    Table 165. ThePharm Corporation Information
    Table 166. ThePharm Description and Business Overview
    Table 167. ThePharm Pharmaceutical Grade Cannabis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 168. ThePharm Pharmaceutical Grade Cannabis Product
    Table 169. ThePharm Recent Developments/Updates
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Pharmaceutical Grade Cannabis Distributors List
    Table 173. Pharmaceutical Grade Cannabis Customers List
    Table 174. Pharmaceutical Grade Cannabis Market Trends
    Table 175. Pharmaceutical Grade Cannabis Market Drivers
    Table 176. Pharmaceutical Grade Cannabis Market Challenges
    Table 177. Pharmaceutical Grade Cannabis Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Pharmaceutical Grade Cannabis
    Figure 2. Global Pharmaceutical Grade Cannabis Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Pharmaceutical Grade Cannabis Market Share by Type in 2023 & 2030
    Figure 4. Dronabinol Product Picture
    Figure 5. Nabilone Product Picture
    Figure 6. Nabiximols Product Picture
    Figure 7. Cannabidiol Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Pharmaceutical Grade Cannabis Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Pharmaceutical Grade Cannabis Market Share by Application in 2023 & 2030
    Figure 11. Oral Medications
    Figure 12. Topical Medications
    Figure 13. Global Pharmaceutical Grade Cannabis Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Pharmaceutical Grade Cannabis Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Pharmaceutical Grade Cannabis Sales (2019-2030) & (Tons)
    Figure 16. Global Pharmaceutical Grade Cannabis Average Price (US$/Ton) & (2019-2030)
    Figure 17. Pharmaceutical Grade Cannabis Report Years Considered
    Figure 18. Pharmaceutical Grade Cannabis Sales Share by Manufacturers in 2023
    Figure 19. Global Pharmaceutical Grade Cannabis Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Pharmaceutical Grade Cannabis Players: Market Share by Revenue in 2023
    Figure 21. Pharmaceutical Grade Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Pharmaceutical Grade Cannabis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Pharmaceutical Grade Cannabis Sales Market Share by Country (2019-2030)
    Figure 24. North America Pharmaceutical Grade Cannabis Revenue Market Share by Country (2019-2030)
    Figure 25. United States Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Pharmaceutical Grade Cannabis Sales Market Share by Country (2019-2030)
    Figure 28. Europe Pharmaceutical Grade Cannabis Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Pharmaceutical Grade Cannabis Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Pharmaceutical Grade Cannabis Revenue Market Share by Region (2019-2030)
    Figure 36. China Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Pharmaceutical Grade Cannabis Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Pharmaceutical Grade Cannabis Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Pharmaceutical Grade Cannabis Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Pharmaceutical Grade Cannabis Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Pharmaceutical Grade Cannabis Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Pharmaceutical Grade Cannabis by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Pharmaceutical Grade Cannabis by Type (2019-2030)
    Figure 57. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Pharmaceutical Grade Cannabis by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Pharmaceutical Grade Cannabis by Application (2019-2030)
    Figure 60. Global Pharmaceutical Grade Cannabis Price (US$/Ton) by Application (2019-2030)
    Figure 61. Pharmaceutical Grade Cannabis Value Chain
    Figure 62. Pharmaceutical Grade Cannabis Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS